PIPages
Labs

Edmund Tsui

University of California-Los Angeles, CA·Medicine & Clinical Research

Uveitis, inflammation inside the eye, is the fifth leading cause of blindness in the developed world. The forms that affect the middle and back of the eye are usually lifelong and cause the most visual loss.

Fields

Medicine & Clinical Research

Public Health & Epidemiology

Topics

uveitis

uveitic macular edema

optical coherence tomography

Grants
1 known grant, through Apr 2031

What they work on

  1. Identify which optical coherence tomography features, such as ellipsoid zone integrity, intraretinal hyperreflective foci and disorganization of retinal inner layers, predict response to therapy for uveitic macular edema across four completed randomized trials.
  2. Determine which OCT biomarkers correlate with baseline visual acuity and predict longitudinal changes in vision in patients with uveitic macular edema, using combined imaging and clinical data from the POINT, MERIT, ADVISE and FAST trials.
  3. Evaluate how OCT biomarkers, including photoreceptor layer and choroidal thickness, relate to inflammatory activity in intermediate, posterior and panuveitis and within selected specific uveitic diseases.

More about the research

A major obstacle in managing them is that clinicians lack objective measurements: deciding whether inflammation is active or treatment is working still rests heavily on subjective examination. This project looks for those objective measures in images that patients already receive.

Why it matters

Patients with chronic uveitis need lifelong monitoring, and clinicians currently have few objective ways to judge inflammation or predict who will respond to treatment. Validated OCT biomarkers, drawn from scans already performed in routine care at no added risk, could allow earlier detection of macular swelling, better tracking of disease activity, and treatment decisions that prevent permanent vision loss and disability.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Researching OCT Biomarkers in UveitiS clinical Trials (ROBUST)

NIH · May 2026 – Apr 2031

Closest labs

Yan Li

Oregon Health & Science University, OR·Biomedical Engineering

Develop ultrahigh-resolution optical coherence tomography capable of imaging the aqueous humor at the front of the eye and the vitreous gel behind it.

Yali Jia

Oregon Health & Science University, OR·Biomedical Engineering

Build a 1-MHz, 120° wide-field, high-resolution OCTA system with GPU real-time processing that captures reliable retinal blood-flow images in a single scan, without stitching images together.

Yannis Paulus

Johns Hopkins University, MD·Biomedical Engineering

Upgrade a combined photoacoustic microscopy, optical coherence tomography and fluorescence microscopy system to image rabbit eyes in real time, without harming the eye.

The school

University of California-Los Angeles: 84 labs on PI Pages, $1.9B a year on research, 803 research doctorates a year.

More about University of California-Los Angeles

Reach out

A start for your email. Fill in the brackets.